Effect of clindamycin on acute and chronic toxoplasmosis in mice
about
Clinically Available Medicines Demonstrating Anti-Toxoplasma ActivityIn vivo assessment of antimicrobial agents against Toxoplasma gondii by quantification of parasites in the blood, lungs, and brain of infected miceIn vitro and in vivo effects of doxycycline on Toxoplasma gondiiRemarkable in vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against tachyzoites and tissue cysts of Toxoplasma gondiiSynergistic effect of clindamycin and atovaquone in acute murine toxoplasmosisAzithromycin, a macrolide antibiotic with potent activity against Toxoplasma gondiiTrovafloxacin is active against Toxoplasma gondiiTreatment with interleukin 12 in combination with atovaquone or clindamycin significantly increases survival of mice with acute toxoplasmosisAlternative treatment approach to cerebral toxoplasmosis in HIV/AIDS: experience from a resource-poor setting.Comparison of mutants of Toxoplasma gondii selected for resistance to azithromycin, spiramycin, or clindamycinFeline ocular toxoplasmosis.Trimethoprim-sulfamethoxazole in murine toxoplasmosis.Paradoxical effect of clindamycin in experimental, acute toxoplasmosis in cats.Clindamycin in a murine model of toxoplasmic encephalitisNew micromethod to study the effect of antimicrobial agents on Toxoplasma gondii: comparison of sulfadoxine and sulfadiazine individually and in combination with pyrimethamine and study of clindamycin, metronidazole, and cyclosporin A.Parasiticidal effect of clindamycin on Toxoplasma gondii grown in cultured cells and selection of a drug-resistant mutant.Effect of clindamycin on pneumonia from reactivation of Toxoplasma gondii infection in miceIn Vitro and in Vivo Effects of Nitrofurantoin on Experimental Toxoplasmosis.Simple and efficient model systems of screening anti-Toxoplasma drugs in vitro.Recent developments in the prevention and treatment of congenital toxoplasmosis.Evaluation of the efficacy and safety of clindamycin plus pyrimethamine for induction and maintenance therapy of toxoplasmic encephalitis in AIDS.Evaluation of anti-coccidial effects of 1-[4-(4-nitrophenoxy)phenyl]propane-1-one and identification of its potential target proteins in Toxoplasma gondii.Current problems in the management of AIDS patients.Toxoplasma gondii and schizophrenia: a review of published RCTs.Plasma pyrimethamine concentrations during long-term treatment for cerebral toxoplasmosis in patients with AIDSEffect of clindamycin on intracellular replication, protein synthesis, and infectivity of Toxoplasma gondii.Opportunistic/nosocomial infections. Treatment and developmental therapeutics. Toxoplasmosis.Drug resistance and distribution of R factors in Salmonella strains.Lympho-glandular toxoplasmosis. A diagnosis often missed.The potential role of azithromycin in the treatment of prophylaxis of toxoplasmosis.Anticoccidial activity of 2-sulfamoyl-4,4-diaminodiphenylsulfone, sulfadiazine, pyrimethamine and clindamycin in cats infected with Toxoplasma gondii.Efficacy of clindamycin/primaquine versus trimethoprim/sulfamethoxazole in primary treatment of Pneumocystis carinii pneumonia.Activity of gamma interferon in combination with pyrimethamine or clindamycin in treatment of murine toxoplasmosis.In vivo and in vitro activity of roxithromycin against Toxoplasma gondii in mice.Licochalcone A: An effective and low-toxicity compound against Toxoplasma gondii in vitro and in vivo.Canine Cutaneous Neosporosis: Clinical Improvement with Clindamycin
P2860
Q26782581-A3EFA584-B55D-4D1A-BC3E-B78A7FC73DD4Q28331625-FE83CF49-B239-4D0A-B3C7-2CABEF5AFF69Q28335472-E2E11AD6-D9DA-4908-B8DE-39411152B097Q28335576-C132B298-C420-4C79-B78B-7E2725365923Q28343549-CF581612-3A6E-4FB2-875C-9D45927391C7Q28359844-ED71DF84-3868-45F9-8C77-E94DA37E6EA3Q28379193-16B5A33C-7E17-41C4-979F-6B88963716F0Q28379387-F3AA4D88-C4AA-48EB-9CFF-58B802762033Q33418764-06BC4B87-E526-4161-B2F7-7B40CC335756Q33746997-FC78A392-D23D-417A-94B1-1DB236050BACQ34276691-6F703075-76B2-49CA-BD3A-0A74EA397E3FQ34965537-7A492C55-3C00-4F6F-8093-A21B67016DFAQ35124789-6F0A2968-A938-4657-86CF-3330221ADBA4Q35538321-9B239446-ECF1-4F01-A7CF-3305F22A061CQ35639477-4B4F1C3D-B1DF-485C-9C40-495249662E5FQ35836436-BD32057C-A1EE-445C-9933-06A4D54A6A70Q36753517-239D297B-CCBA-4067-91FB-9C11E8411FECQ36911896-76871734-D78D-4D7E-8E2D-77B56853DEC6Q37999103-51F8B406-A150-4D77-9AE3-FD46C51481E9Q38774985-5DE3AABA-2D93-41CC-891E-8C3185C89C74Q39123475-870B5938-1D08-44EF-8015-8F09D0B5E60EQ39193220-108E74F0-361E-4079-9202-5CECC05712CFQ39217909-34EE2D67-3204-431E-BD1D-D8E67CD3F49FQ39308979-B0CAD495-17E8-4B52-A8A4-6EA740781A3BQ39782411-75083072-F1FA-48AB-BCCE-7EF273705002Q39883651-EEBC6FB7-E082-4A7E-ABAC-FFFBBE88978FQ40865388-945D6FE4-57E6-4879-B424-9C57368327FAQ40945676-578A2885-3D0B-47C5-A74C-960A02DA34AEQ40984091-D937856E-8456-4D35-BEF2-7A3AD300776DQ41000192-787A423B-BB83-4ACB-B48B-A2E7D26F1252Q41031773-49B12D6F-B4AB-4F5F-907C-7E863F984508Q45300468-27C121D2-C418-4ADE-A78A-F6724045D719Q46834636-6F1040B4-3072-4F7D-B16B-E3BAC4A9ED1EQ48222467-D2F09BF1-055F-43F6-A641-5CB847F6AC06Q52569580-6440DCCB-E038-4138-8FE6-80537E68EF0FQ58708688-9A5B7C5D-1635-4BD4-BFB5-8A4345C08C67
P2860
Effect of clindamycin on acute and chronic toxoplasmosis in mice
description
1974 nî lūn-bûn
@nan
1974 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1974 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1974年の論文
@ja
1974年論文
@yue
1974年論文
@zh-hant
1974年論文
@zh-hk
1974年論文
@zh-mo
1974年論文
@zh-tw
1974年论文
@wuu
name
Effect of clindamycin on acute and chronic toxoplasmosis in mice
@ast
Effect of clindamycin on acute and chronic toxoplasmosis in mice
@en
Effect of clindamycin on acute and chronic toxoplasmosis in mice
@nl
type
label
Effect of clindamycin on acute and chronic toxoplasmosis in mice
@ast
Effect of clindamycin on acute and chronic toxoplasmosis in mice
@en
Effect of clindamycin on acute and chronic toxoplasmosis in mice
@nl
prefLabel
Effect of clindamycin on acute and chronic toxoplasmosis in mice
@ast
Effect of clindamycin on acute and chronic toxoplasmosis in mice
@en
Effect of clindamycin on acute and chronic toxoplasmosis in mice
@nl
P2860
P356
P1476
Effect of clindamycin on acute and chronic toxoplasmosis in mice
@en
P2093
Remington JS
P2860
P304
P356
10.1128/AAC.5.6.647
P407
P577
1974-06-01T00:00:00Z